Msi2 Activators
Msi2 Activators encompass a collection of chemical compounds that indirectly enhance the functional activity of Msi2 through modulation of various cellular signaling pathways and processes. Compounds such as Forskolin and Rolipram act on the cAMP signaling pathway; Forskolin achieves this by directly stimulating adenylyl cyclase, thus increasing intracellular cAMP and subsequently activating PKA, which can phosphorylate and influence proteins that regulate RNA binding andtranslation, thereby potentially enhancing Msi2 activity. Rolipram, on the other hand, inhibits the degradation of cAMP by targeting PDE4, consequently increasing PKA activity that may augment Msi2's role in mRNA regulation. Similarly, the BET bromodomain inhibitor I-BET151 alters gene expression patterns, which could lead to the upregulation of proteins that interact with and support Msi2's functional activity. In the realm of kinase signaling, SP600125, PD98059, and D4476 work by inhibiting JNK, MEK, and casein kinase 1, respectively. This inhibition may stabilize mRNA targets of Msi2, modify the translational landscape to favor Msi2 activity, or enhance the stability and function of Msi2-regulated mRNA transcripts.
Furthermore, LY294002 and Rapamycin each challenge pivotal signaling axes-PI3K and mTOR-potentially leading to a cellular milieu that accentuates Msi2's post-transcriptional regulatory functions or its role in cell fate determination. In addition, SB431542's inhibition of TGF-beta signaling might indirectly bolster Msi2's involvement in stem cell maintenance. The selective ROCK inhibitor Y-27632 might influence Msi2 activity by altering cytoskeletal dynamics, affecting Msi2's cellular localization and mRNA regulatory functions. Compounds like 5-Azacytidine and ZM447439, which modulate DNA methylation and cell cycle progression respectively, could also impact the functional activity of Msi2 by changing the expression of interacting proteins or by affecting cellular states that Msi2 helps regulate.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing cAMP levels within the cell. Elevated cAMP activates PKA, which can phosphorylate proteins involved in the regulation of RNA binding and translation, thereby potentially enhancing Msi2 activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), which degrades cAMP. By preventing cAMP degradation, Rolipram could indirectly increase PKA activity, which may, in turn, boost Msi2's RNA binding and translational regulatory functions. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
I-BET151 is a BET bromodomain inhibitor that acts on chromatin remodeling. By altering gene expression patterns, this compound could upregulate proteins that interact with Msi2, leading to an indirect enhancement of Msi2's functional activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK signaling pathway. By inhibiting JNK, which is involved in mRNA decay, SP600125 could indirectly stabilize mRNAs that are targets of Msi2, thereby enhancing the activity of Msi2. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor which, by altering MAPK/ERK signaling, could modify the translation of proteins interacting with Msi2, indirectly increasing the functional activity of Msi2 in RNA binding and regulation. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 is an inhibitor of the TGF-beta signaling pathway. By inhibiting this pathway, SB431542 might create a cellular context that indirectly increases Msi2's role in the regulation of stem cell renewal and differentiation. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective ROCK inhibitor. By modifying cytoskeletal dynamics and cell adhesion, this compound could affect the cellular localization and function of Msi2, potentially enhancing its activity in mRNA regulation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor which leads to DNA demethylation. This change in the epigenetic landscape could result in altered expression of factors that modulate Msi2's function. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
ZM447439 is an Aurora kinase inhibitor that affects cell cycle progression. By influencing the cell cycle, it could potentially increase the activity of Msi2 in cell fate decisions and maintenance of stemness. | ||||||
Casein Kinase I Inhibitor, D4476 | 301836-43-1 | sc-202522 | 1 mg | $99.00 | 6 | |
D4476 is a casein kinase 1 inhibitor. Since Msi2 is involved in RNA binding and translational regulation, inhibition of casein kinase 1 may indirectly enhance the stability and function of Msi2-regulated mRNA transcripts. | ||||||